Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Evelo Biosciences Inc
(NQ:
EVLO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 11, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evelo Biosciences Inc
< Previous
1
2
3
4
5
6
7
Next >
Why Is Surgalign (SRGA) Stock Down 55% Today?
June 20, 2023
Surgalign (SRGA) stock is taking a beating on Tuesday after the spine solutions company filed for Chapter 11 bankruptcy.
Via
InvestorPlace
Why Is Evelo Biosciences (EVLO) Stock Up 51% Today?
June 20, 2023
Evelo Biosciences (EVLO) stock is rising higher on Tuesday after the clinical-stage biotechnology company reached a new standstill agreement.
Via
InvestorPlace
Why Cano Health Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
June 20, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 20, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all the latest news for Tuesday morning!
Via
InvestorPlace
Why Is Atomera (ATOM) Stock Up 34% Today?
April 27, 2023
Atomera (ATOM) stock is taking off on Thursday following the release of its earnings report for the first quarter of 2023!
Via
InvestorPlace
Why Is Evelo Biosciences (EVLO) Stock Up 78% Today?
April 27, 2023
Evelo Biosciences (EVLO) stock is on the rise Thursday after the company said it's shifting focus toward EV development.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
June 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 16, 2023
Via
Benzinga
Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June
June 16, 2023
U.S. stocks traded lower toward the end of trading, with Nasdaq Compsoite dropping around 80 points on Friday. The Dow traded down 0.24% to 34,324.18 while the NASDAQ fell 0.59% to 13,701.06. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 16, 2023
Via
Benzinga
Crude Oil Rises; Adobe Posts Upbeat Results
June 16, 2023
U.S. stocks traded slightly higher midway through trading, with Dow Jones gaining around 20 points on Friday. The Dow traded up 0.06% to 34,428.13 while the NASDAQ rose 0.05% to 13,789.23. The S&P 500,...
Via
Benzinga
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 16, 2023
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 16, 2023
Via
Benzinga
Why Clene Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
June 16, 2023
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) shares gained 192.8% to $0.2427 in pre-market trading. Evelo Biosciences was granted U.S. patent #11672834 for "Prebiotic Compositions And Methods Of Use...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
May 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 28, 2023
Via
Benzinga
Why Hitek Global Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
April 28, 2023
Gainers
Via
Benzinga
Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 28, 2023
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 28, 2023
The biggest pre-market stock movers are a hot topic traders are going to want to know about with all the latest news on Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
April 27, 2023
Via
Benzinga
Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 27, 2023
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 27, 2023
Via
Benzinga
Why Is Impinj (PI) Stock Down 25% Today?
April 27, 2023
Impinj (PI) stock is falling on Thursday after the radio-frequency chipmaker released its earnings report for the first quarter of 2023.
Via
InvestorPlace
Why Is Baudax Bio (BXRX) Stock Down 52% Today?
April 27, 2023
Baudax Bio (BXRX) stock is falling hard on Thursday after the pharmaceutical company announced a $4 million public stock offering.
Via
InvestorPlace
Why Meta Platforms Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
April 27, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 27, 2023
The biggest pre-market stock movers are ready to go as we dive into the latest news traders need to know about on Thursday!
Via
InvestorPlace
Why Chipotle Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 26, 2023
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 105% to $0.1730 after the company issued a letter to shareholders.
Via
Benzinga
Evelo Biosciences' Atopic Dermatitis Study Cohort Misses Primary Goal Again, Shuts Study, Lays Off More Staff
April 26, 2023
Evelo Biosciences Inc (NASDAQ: EVLO) said its fourth cohort of the EDP1815 Phase 2 trial in atopic dermatitis, consistent with the first three cohorts, failed to meet the primary endpoint of the...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.